Why India Isn’t Paying Attention To Drugs For Rare Diseases, Reason Behind High Cost Medicines and Delay in Diagnosis

Why India Isn’t Paying Attention To Drugs For Rare Diseases, Reason Behind High Cost Medicines and Delay in Diagnosis

Dr Ramaiah Muthyala questions why despite being the pharmacy bowl of the world, India cannot manufacture drugs for rare diseases inhouse.

Yesterday, as Sudha Murty took centerstage at Parliament urging for a vaccination programme to combat cervical cancer, I was…

[ad_2]

Source link

More From Author

Lotto Dstny set to lose another two important riders as budget uncertainties tie their hands

Lotto Dstny set to lose another two important riders as budget uncertainties tie their hands

LSE election night on the 2024 results

LSE election night on the 2024 results

Leave a Reply

Your email address will not be published. Required fields are marked *